BMS is building a massive AI factory on NVIDIA Vera Rubin
NVIDIA Blog · rss · 2026-07-20
NVIDIA says Bristol Myers Squibb is deploying a second DGX SuperPOD, this time built on eight DGX Vera Rubin NVL72 systems, to power life-science research at larger scale.
Key points:
- BMS is unifying its AI environment across sites into a single data plane
- The new system is presented as up to 10x more performant per megawatt than the infrastructure it replaces
- Researchers will use NVIDIA’s BioNeMo Agent Toolkit and plain-English interfaces for predictions, model training, and agentic workflows
- The company says AI is already helping with target identification, compound expansion, and lead optimization in drug discovery
The broader message is that BMS wants AI to become a shared research platform for every scientist, not a small specialized cluster.
More from Companies & People
- Cordant exits stealth with an $8M seed round for payments visibility tools — LexSokolin · 2026-07-21
- Forgepoint AI launches Frank, an AI inside-sales rep for manufacturers — tkexpress11 · 2026-07-21
- Anthropic’s compute lead may be huge, but the benchmark gap is only about six months — xeophon · 2026-07-21
- Zhipu acquires a compiler-team spinout to optimize AI inference on domestic chips — zephyr_z9 · 2026-07-21
- Claude’s Delhi builders event drew 120 people to talk agentic AI and productivity — rudrank · 2026-07-21
- Why VCs Are Loudly Backing Open Source AI: Frontier Monopolies Threaten Their Survival — chris_j_paxton · 2026-07-21